Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. Supreme Court nominee's confirmation hearings on track, McConnell says

Published 10/03/2020, 12:53 PM
Updated 10/03/2020, 03:15 PM
© Reuters. FILE PHOTO:  U.S. Senate Majority Leader McConnell walks through the U.S. Capitol building in Washington

By Idrees Ali

WASHINGTON (Reuters) - U.S. Senate Majority Leader Mitch McConnell said on Saturday that Supreme Court nominee Amy Coney Barrett's confirmation hearings will proceed as planned even though two Republicans on the Judiciary Committee had contracted the coronavirus.

Senators Thom Tillis and Mike Lee, who sit on the panel that will preside over the hearings, tested positive for COVID-19 in the past day. Both were at the White House on Sept. 26 when President Donald Trump introduced Barrett as his nominee to replace Supreme Court Justice Ruth Bader Ginsburg, who died last month.

Trump was taken to Walter Reed National Military Medical Center near Washington on Friday just hours after he was diagnosed with COVID-19.

"Previously-scheduled floor activity will be rescheduled until after October 19th ... The important work of the Senate’s committees can and will continue as each committee sees fit," McConnell said in a statement.

McConnell added that the Republican-controlled Judiciary Committee would start Barrett's confirmation hearings on Oct. 12 as previously planned. Senators have the option of attending the hearings in person or remotely.

Senate Democratic leader Chuck Schumer said McConnell's decision was dangerous and reckless.

"If it’s too dangerous to have the Senate in session it is also too dangerous for committee hearings to continue," Schumer said in a statement.

On Friday, Judiciary Committee Chairman Lindsey Graham (NYSE:GHM) spoke to Trump and the first thing the president asked about was the Senate’s plan for Barrett’s confirmation, an aide to Graham said.

McConnell's announcement, however, could mean that no new coronavirus aid bill will be approved by Congress in the coming days, despite negotiations this week between House of Representatives Speaker Nancy Pelosi and White House officials.

© Reuters. FILE PHOTO:  U.S. Senate Majority Leader McConnell walks through the U.S. Capitol building in Washington

Those talks resumed after talks reached an impasse in August. Congressional Democrats were seeking more than $2 trillion in new aid to battle the pandemic and many Republican senators were either supporting a significantly smaller response or no further funding at this time.

Latest comments

Signing his own career death sentence
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.